Assessment of histological features and outcome of interferon therapy in chronic hepatitis C-Reference-Cited by-同舟云学术

Assessment of histological features and outcome of interferon therapy in chronic hepatitis C

Published:1996-01 Issue:1 Volume:31 Page:69-74
ISSN:0944-1174
Container-title:Journal of Gastroenterology
language:en
Short-container-title:J Gastroenterol

Author:

Kumagai Naoki,Kuramochi Shigeru,Toda Kyouko,Iwabuchi Naoto,Tsuchimoto Kanji,Tsunematsu Satoshi,Saito Hidetsugu,Morizane Toshio,Tsuchiya Masaharu,Ishii Hiromasa

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology

Link

http://link.springer.com/content/pdf/10.1007/BF01211189.pdf

Reference23 articles.

1. Choo Q-L, Kuo G, Weiner AJ, et al. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989;244:359?362.

2. Devis GL, Balart LA, Schiff ER, et al. Treatment of chronic hepatitis C with recombinant interferon alfa. N Engl J Med 1989;321:1506?1511.

3. Di Bisceglie AM, Martin P, Kassianides C, et al. Recombinant interferon alfa therapy for chronic hepatitis C. N Engl J Med 1989;321:1506?1511.

4. Shindo M, Di Biseglie AM, Hoofnagel JH. Long-term follow-up of patients with chronic hepatitis C treated with ?-interferon. Hepatology 1992;15:1013?1016.

5. Devis GL, Hepatitis C virus antibody in patients with chronic autoimmune hepatitis: Pitfalls in diagnosis and implication for treatment. Mayo Clin Proc 1991;66:647?650.

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real‐world efficacy and safety of sofosbuvir + ribavirin for hepatitis C genotype 2: A nationwide multicenter study by the Japanese Red Cross Liver Study Group;Hepatology Research;2018-10-20

2. Sofosbuvir and daclatasvir plus ribavirin treatment improve liver function parameters and clinical outcomes in Egyptian chronic hepatitis C patients;European Journal of Gastroenterology & Hepatology;2017-12

3. Daclatasvir and asunaprevir treatment improves liver function parameters and reduces liver fibrosis markers in chronic hepatitis C patients;Hepatology Research;2016-02-16

4. Chronic hepatitis: Role of diffusion-weighted imaging and diffusion tensor imaging for the diagnosis of liver fibrosis and inflammation;Journal of Magnetic Resonance Imaging;2008-07

5. Diffusion-Weighted MRI for Quantification of Liver Fibrosis: Preliminary Experience;American Journal of Roentgenology;2007-10